Trial Profile
A comparative double-blind controlled for the effect of fenofibrate treatment on the expression of genes of cholesterol homeostasis, inflammation and cell proliferation in carotid plaques asymptomatic arteriosclerosis. [Etude controlee comparative en double aveugle de l'effet d'un traitement par le fenofibrate sur l'expression des genes de l'homeostasie du cholesterol, de l'inflammation et de la proliferation cellulaire dans les plaques arterosclereuses carotidiennes asymptomatiques.]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2011
Price :
$35
*
At a glance
- Drugs Fenofibrate (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms FENOGEN
- 29 Aug 2011 New trial record